ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 890

$942K Total Retail Price of All Prescriptions

Rank: 55 out of 890

890 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

4% of this provider’s 13,749 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 579 522 1 2
AMLODIPINE BESYLATE 525 474 2 1
PRAVASTATIN SODIUM 467 409 3 10
FUROSEMIDE 447 421 4 7
METFORMIN HCL 430 339 5 6
LISINOPRIL 375 332 6 4
OMEPRAZOLE 358 307 7 8
LOSARTAN POTASSIUM 335 305 8 29
WARFARIN SODIUM 285 268 9 24
SIMVASTATIN 275 242 10 5
POTASSIUM CHLORIDE 273 265 11 11
HYDROCHLOROTHIAZIDE 231 189 12 9
METOPROLOL TARTRATE 223 210 13 15
ALENDRONATE SODIUM 209 200 14 38
NEXIUM 209 181 14 14
NAMENDA 206 206 16 36
ATENOLOL 204 173 17 23
TAMSULOSIN HCL 185 165 18 32
CLONIDINE HCL 180 139 19 35
LISINOPRIL-HYDROCHLOROTHIAZIDE 173 128 20 21
DONEPEZIL HCL 166 166 21 30
BENAZEPRIL HCL 160 143 22 44
LANTUS 155 139 23 50
GABAPENTIN 146 122 24 12
GLIPIZIDE 146 129 24 62
TRAZODONE HCL 145 131 26 40
DIOVAN 142 138 27 33
LOVASTATIN 141 120 28 46
METOPROLOL SUCCINATE 137 115 29 17
EXELON 131 131 30 113
PANTOPRAZOLE SODIUM 125 108 31 34
CITALOPRAM HBR 123 112 32 20
CARVEDILOL 117 97 33 22
LOSARTAN-HYDROCHLOROTHIAZIDE 117 105 33 57
MELOXICAM 116 77 35 18
RANITIDINE HCL 113 85 36 49
AZITHROMYCIN 108 98 37 37
PROAIR HFA 108 64 37 55
CIPROFLOXACIN HCL 105 87 39 58
ATORVASTATIN CALCIUM 103 78 40 13
SERTRALINE HCL 100 83 41 26
ESCITALOPRAM OXALATE 99 98 42 51
MIRTAZAPINE 95 83 43 82
DIPYRIDAMOLE 93 82 R 44 264
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 80 45 76
GLYBURIDE 89 82 R 46 83
CEFTRIAXONE 89 89 46 239
NAPROXEN SODIUM 86 79 48 223
PREMARIN 84 82 R 49 105
JANUVIA 82 82 50 59
SYNTHROID 78 52 51 53
CLOPIDOGREL 78 68 51 28
AMOXICILLIN 70 55 53 94
PLAVIX 69 62 54 42
ALLOPURINOL 68 68 55 31
DICLOFENAC SODIUM 68 65 55 96
DIOVAN HCT 66 66 57 48
ADVAIR DISKUS 65 59 58 52
AMLODIPINE BESYLATE-BENAZEPRIL 65 58 58 41
PREDNISONE 64 48 60 47
RAMIPRIL 63 53 61 80
AMITRIPTYLINE HCL 62 49 R 62 43
MEGESTROL ACETATE 62 62 R 62 92
VERAPAMIL ER 61 49 64 87
QUETIAPINE FUMARATE 60 53 65 73
SPIRONOLACTONE 60 58 65 85
FLUTICASONE PROPIONATE 60 56 65 39
NAPROXEN 56 45 68 84
PERPHENAZINE-AMITRIPTYLINE 56 46 R 68 329
SPIRIVA 55 50 70 66
CYMBALTA 54 50 71 45
AMOX TR-POTASSIUM CLAVULANATE 53 39 72 132
BYSTOLIC 53 44 72 86
RISPERIDONE 53 52 72 78
GLIMEPIRIDE 52 40 75 27
HUMULIN R 52 50 75 260
COMBIVENT 51 45 77 144
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.